Analysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target at $8.42

LifeStance Health Group, Inc. (NASDAQ:LFST) has been assigned an average rating of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $8.50.

Several research analysts have issued reports on the company. Wall Street Zen upgraded LifeStance Health Group from a “hold” rating to a “buy” rating in a research report on Saturday. BTIG Research initiated coverage on shares of LifeStance Health Group in a report on Friday, July 25th. They issued a “buy” rating and a $8.00 price target for the company. Finally, UBS Group raised their price objective on shares of LifeStance Health Group from $8.50 to $9.00 and gave the company a “buy” rating in a research note on Friday, August 8th.

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST opened at $4.66 on Wednesday. LifeStance Health Group has a 52 week low of $3.74 and a 52 week high of $8.61. The company has a 50-day moving average price of $4.72 and a 200 day moving average price of $6.14. The company has a market cap of $1.81 billion, a P/E ratio of -93.20 and a beta of 1.13. The company has a quick ratio of 1.47, a current ratio of 1.48 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST) last issued its earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.02. The business had revenue of $345.31 million during the quarter, compared to the consensus estimate of $345.05 million. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%. The company’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same period in the prior year, the business posted ($0.06) EPS. Research analysts predict that LifeStance Health Group will post -0.18 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Ujjwal Ramtekkar sold 16,000 shares of LifeStance Health Group stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the completion of the transaction, the insider owned 113,435 shares of the company’s stock, valued at $673,803.90. The trade was a 12.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 6.60% of the company’s stock.

Hedge Funds Weigh In On LifeStance Health Group

Several hedge funds have recently added to or reduced their stakes in LFST. Choreo LLC raised its position in LifeStance Health Group by 6.4% during the first quarter. Choreo LLC now owns 27,420 shares of the company’s stock worth $183,000 after acquiring an additional 1,661 shares during the last quarter. LPL Financial LLC increased its stake in shares of LifeStance Health Group by 6.0% during the 4th quarter. LPL Financial LLC now owns 37,584 shares of the company’s stock worth $277,000 after purchasing an additional 2,127 shares in the last quarter. Invesco Ltd. raised its position in shares of LifeStance Health Group by 1.4% during the 1st quarter. Invesco Ltd. now owns 164,384 shares of the company’s stock worth $1,095,000 after purchasing an additional 2,238 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in LifeStance Health Group by 2.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company’s stock valued at $1,023,000 after buying an additional 3,305 shares in the last quarter. Finally, Legal & General Group Plc grew its holdings in LifeStance Health Group by 2.4% during the 2nd quarter. Legal & General Group Plc now owns 144,263 shares of the company’s stock valued at $746,000 after buying an additional 3,331 shares during the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.